Hawaii HB 1667: RELATING TO HEALTH.

Status: Reported from CPC (Stand. Com. Rep. No. 538-22) as amended in HD 2, recommending referral to FIN. (as of 2022-02-17)

State: Hawaii · Session: 2022 Regular Session · Bill: HB 1667

Subjects: Clinical Laboratory Directors, Clinical Laboratory Improvement Amendments Waived Tests, Pharmacies, Pharmacists

Sponsors: GATES, NISHIMOTO, TAM, YAMANE

View Hawaii HB 1667 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.